News
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy
New guidance highlights evolving surgical procedure applications of reticulated open cell foam (ROCF) dressings to support patient safety, surgical outcomes and future standards of care Solventum(TM) Prevena(TM) Therapy is the only closed incision negative pressure therapy system with fully integrated linear and area dressings solely indicated for closed incisions that utilize ROCF technology ST. PAUL, Minn., Dec. 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced the consensus...
Solventum Announces $1 Billion Share Repurchase Program
ST. PAUL, Minn., Nov. 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its Board of Directors has approved a share repurchase program, which authorizes the Company to purchase up to $1 billion of the Company's outstanding common stock. "Our strong financial performance, operating cash generation, and healthy balance sheet give us the flexibility to invest in opportunities that accelerate sustainable growth, pursue targeted tuck-in M&A-such as today's announced acquisition of...
Solventum Announces Agreement to Acquire Acera Surgical
Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space, a part of the broader regenerative tissue matrices category within acute care settings, a $900 million market segment in the U.S. Accelerates Solventum's business transformation through the acquisition of a strategically aligned asset in a technology adjacency ST. PAUL, Minn., Nov. 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today it has entered into a definitive agreement to acquire...
Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B
Accelerates Solventum's business transformation and sharpens focus on strategic areas for growth to deliver long-term shareholder value Strengthens balance sheet with proceeds to be used primarily for debt paydown ST. PAUL, Minn., Feb. 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced it has entered into a definitive agreement to sell its Purification & Filtration1 business to Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") for $4.1 billion. Solventum expects the...
Solventum Appoints Heather Knight as Chief Commercial Officer
ST. PAUL, Minn., Oct. 21, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today the appointment of Heather Knight as Chief Commercial Officer, effective November 10, 2025. In this newly created role, Ms. Knight will oversee global commercial and R&D operations across Solventum's MedSurg, Dental Solutions and Health Information Systems segments, and will report directly to CEO Bryan Hanson. Ms. Knight brings over 30 years of leadership experience in the MedTech industry. Most recently,...
Solventum Completes Acquisition of Acera Surgical
Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space in acute care settings in the U.S. Accelerates Solventum's business transformation through the acquisition of a strategically aligned asset in a technology adjacency ST. PAUL, Minn., Dec. 23, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today it has completed the acquisition of Acera Surgical (Acera), a privately held bioscience company focused on developing and commercializing fully engineered...
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength
ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it has achieved the Diamond Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC), the highest recognition for supply chain strength in healthcare. This certification validates Solventum's MedSurg segment's ability to deliver critical healthcare products consistently, even during supply disruptions to help ensure uninterrupted patient care. "The Diamond Level Resiliency...
Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition: Front-end Imaging
ST. PAUL, Minn., Feb. 5, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) Solventum today announced that its AI-powered radiology speech reporting solution, Solventum(TM) Fluency(TM) for Imaging, has ranked #1 in the 2025 Best in KLAS Awards-Software and Services Report for the fifth time. Enabling faster, more accurate documentation, Solventum Fluency for Imaging helps radiologists save time, reduce burnout and improve efficiency by streamlining the reporting process. The technology integrates...
Solventum Launches Attestâ„¢ eBowie-Dick Test System Revolutionizing Sterilization Assurance
ST. PAUL, Minn., March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest(TM) eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization testing that eliminates the need for visual interpretation of results and manual documentation. In less than five seconds, the eBowie-Dick System's simple "pass" or "fail" digital display provides definitive test results and creates an automated...
Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization
The Attest(TM) Super Rapid VH2O2 Clear Challenge Pack integrates biological and chemical performance indicators in a ready-to-use design to support every load monitoring1 U.S. hospital infections affect 1 in 31 patients;2 new all-in-one solution is aimed at making expert-recommended safety practices in steam sterilization3 feasible for VH2O2 low-temperature method Test pack is U.S. FDA-cleared for routine monitoring across multiple sterilizer brands, models and cycle types, and is designed to...
Solventum Named a Best Company to Work for by U.S. News & World Report
Recognized among the top 25 percent of companies in healthcare and research, and top 25 percent of companies in the Midwest in just 14 months as a new company Award highlights success in phase one of Solventum's three-phased Transformation Plan ST. PAUL, Minn., June 18, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), a global leader in innovative medical technology and solutions, today announced U.S. News & World Report has named the company among its 2025-2026 list of Best Companies to Work...
Solventum Reports First Quarter 2025 Financial Results
Reported sales increased 2.6%; organic sales increased 4.3% Increases full year organic sales growth outlook by 50 bps to +1.5% to +2.5% ST. PAUL, Minn., May 8, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Sales increased 2.6% to $2.1 billion; up 4.3% on an organic basis GAAP diluted earnings per share of $0.78; adjusted diluted earnings per share of $1.34 Operating cash flow of $29...
Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance
Reported sales increased 1.9% to $2.074 billion; organic sales increased 2.3% GAAP diluted Earnings Per Share (EPS) of $0.17; adjusted EPS1 of $1.41 Generated $219 million in cash from operations; free cash flow of $92 million Introduces full-year 2025 organic sales growth, adjusted EPS and free cash flow guidance ST. PAUL, Minn., Feb. 27, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the fourth quarter ended December 31, 2024. "Solventum executed another...
Solventum Reports Third Quarter 2025 Financial Results
Reported sales increased 0.7%; organic sales increased 2.7% Expects full year organic sales growth to be at the high end of +2.0% to +3.0% range Increases full year adjusted earnings per share outlook to $5.98 to $6.08 Announces 4-year 'Transform for the Future' initiative ST. PAUL, Minn., Nov. 6, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Sales increased 0.7% to $2.1 billion; up...
Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations
In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to focus on longevity and durability of permanent same-day restorative dental offerings, reaffirming its commitment to solving industry's toughest problems Partnership aims to integrate innovative new material science and disruptive technology like chairside 3D printing to optimize workflows, enhance procedural efficiency and benefit both patients and practitioners ST....
Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City
Learn more about Solventum's long-term strategy to accelerate growth Join in person or via virtual webcast ST. PAUL, Minn., Feb. 26, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will host an investor day on Thursday, March 20, 2025, beginning at approximately 1:00 p.m. Eastern Standard Time. The event will be held in New York City and simultaneously webcast online. More information about this event, including registration information, may be accessed by visiting...
Solventum to Participate in the 2025 BofA Securities Health Care Conference
ST. PAUL, Minn., May 8, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the 2025 BofA Securities Health Care Conference on Tuesday, May 13, 2025, beginning at approximately 2:20 p.m. PST in Las Vegas, NV. A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com. About Solventum At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new...
Solventum to Participate in the 2025 Goldman Sachs Health Care Conference
ST. PAUL, Minn., June 3, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the Goldman Sachs 46th Annual Global Health Care Conference on Tuesday, June 10, 2025, beginning at approximately 4:00 p.m. EDT in Miami, FL. A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com. About Solventum At Solventum, we enable better, smarter, safer healthcare to improve lives. As a...
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference
ST. PAUL, Minn., Nov. 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday, Dec. 2, 2025, beginning at approximately 10:00 a.m. EST in New York, NY. A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com. About Solventum At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company...
Solventum to Participate in the 2025 Stifel Healthcare Conference
ST. PAUL, Minn., Nov. 3, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the Stifel Healthcare Conference on Wednesday, Nov. 12, 2025, beginning at approximately 11:20 a.m. EST in New York, NY. A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com. About Solventum At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a...
Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day
Provides 2028 Targets for Revenue Growth, Margin Expansion, and Free Cash Flow ST. PAUL, Minn., March 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long-range plan (LRP) to drive growth and value creation. "Solventum has tremendous potential, with attractive businesses, large and growing markets, and highly regarded brands. We have undertaken a significant transformation...
Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025
ST. PAUL, Minn., April 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2025 financial results on Thursday, May 8, 2025, after the U.S. financial markets close. After the release, Solventum management will host a webcast to discuss the results and its business. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Thursday, May 8, 2025 Time: 3:30 p.m. CST / 4:30 p.m. EST Location:...
Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Earnings on February 27, 2025
Company to host an Investor Day in March 2025 ST. PAUL, Minn., Jan. 30, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its fourth quarter fiscal year 2024 financial results on Thursday, February 27, 2025, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results and fiscal year 2025 outlook. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date:...
Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025
ST. PAUL, Minn., July 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter fiscal 2025 financial results on Thursday, Aug. 7, 2025, after the U.S. financial markets close. After the release, Solventum management will host a webcast to discuss the results and its business. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Thursday, Aug. 7, 2025 Time: 3:30 p.m. CDT / 4:30 p.m. EDT Location:...
Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025
ST. PAUL, Minn., Oct. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter fiscal 2025 financial results on Thursday, Nov. 6, 2025, after the U.S. financial markets close. After the release, Solventum management will host a webcast to discuss the results and its business. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Thursday, Nov. 6, 2025 Time: 3:30 p.m. CST / 4:30 p.m. EST Location:...